SciELO - Scientific Electronic Library Online

vol.32Evaluación de la eficacia de la vacuna contra micoplasma para reducir la infección por el virus de la enfermedad de NewcastleVariables censales vinculadas al proceso de vacunación contra COVID-19 en Chile índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados




  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO



versión impresa ISSN 1025-028Xversión On-line ISSN 1025-0298


SAID, Nourhanne Mohamed et al. Impact of H5N8 duck and chicken viral isolates on the immunological profile of vaccinated specific pathogen free chickens. Vaccimonitor [online]. 2023, vol.32, e12123.  Epub 01-Sep-2023. ISSN 1025-028X.

Nowadays, there is a global concern about outbreaks caused by the highly pathogenic avian influenza virus H5N8 clade which caused devastating losses in the poultry industry sector. This clade was subdivided into two waves: clade from 2014 to 2015 and clade from 2016 until now. In this literature we aimed to evaluate the efficacy of recently used inactivated commercial avian influenza vaccines against two new Egyptian highly pathogenic avian influenza virus H5N8 isolates of clade, A/chicken/Egypt/1526v/2020/H5N8 (H5N8-CH) and A/Duck/Egypt/Qalubia321/2021 (H5N8-D). Three-week-old specific pathogen free chickens were vaccinated with eight types of the most recently used inactivated avian influenza vaccines containing homologous and heterologous virus to the circulating H5N8 isolates. All specific pathogen free chicken groups were bled weekly post vaccination for antibody analysis using two H5N8 isolates of chicken and duck origin as antigen in hemagglutination inhibition test. Also, all vaccinated chicken groups were challenged 4 weeks post vaccination against the H5N8 duck isolate with a dose of 109 EID50/0.1 mL per chicken to measure the protection percentage of the commercial vaccines used. The results showed that vaccines with homologous and heterologous virus showed variable degrees of accepted protection percentage ranged from 90% to 100%, thus it was concluded that not only the genetic and antigenic match of the vaccine strains with the circulating highly pathogenic avian influenza viruses influences vaccine efficiency; other factors, such as manufacturing procedures, adjuvant, antigen content, vaccine dose and administration factors could affect vaccine efficacy, therefore, further vaccine development studies are needed to improve the percentage of protection and prevention of viral shedding against local highly pathogenic avian influenza H5 viruses in Egypt.

Palabras clave : avian influenza; H5N8 virus; influenza vaccines; chickens; ducks.

        · resumen en Español     · texto en Inglés     · Inglés ( pdf )